![](https://www.diabetesnews.com/wp-content/uploads/2012/05/fda_logo_pills-150x150.jpg)
Even though health officials readily admit that diabetes is an urgent public health problem, a new diabetes medicine or device usually finds itself in ninth position on the FDA docket for a pre-market clearance. To understand why requires an understanding of the history of the FDA, and its limitations.